Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yihao Mao

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bio-Medical Materials and Engineering|September 18, 2014
Detection and segmentation of virus plaque using HOG and SVM: toward automatic plaque assayYihao Mao, Hong Liu, Rong Ye, et al.
International Journal of Biological Sciences|May 22, 2023
B cells in tumor metastasis: friend or foe?Yuqiu Xu, Yihao Mao, Yang Lv, et al.
Sensors (Basel, Switzerland)|May 14, 2025
The Research on Path Planning Method for Detecting Automotive Steering Knuckles Based on Phased Array Ultrasound Point CloudYihao Mao, Jun Tu, Huizhen Wang, et al.
Clinical and Translational Medicine|June 22, 2020
Analysis of tumor microenvironment-related key mRNAs and construction of a prognosis signature in colon cancerZhiyuan Zhang, Guodong He, Qingyang Feng, et al.
Genomics|July 10, 2020
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancerZhiyuan Zhang, Qingyang Feng, Caiwei Jia, et al.
Genomics|June 17, 2020
A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I-III rectal cancerZhiyuan Zhang, Meiling Ji, Yang Lv, et al.
International Journal of Cancer|June 7, 2018
Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancerYihao Mao, Qingyang Feng, Peng Zheng, et al.
Cancers|August 26, 2022
High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon CancerPeng Zheng, Yang Lv, Yihao Mao, et al.
Cancers|October 14, 2022
CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant ChemotherapyJiang Chang, Songbin Lin, Yihao Mao, et al.
Journal of Cancer Research and Clinical Oncology|April 20, 2020
High MICB expression as a biomarker for good prognosis of colorectal cancerQingyang Feng, Shanchao Yu, Yihao Mao, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bio-Medical Materials and Engineering|September 18, 2014
Detection and segmentation of virus plaque using HOG and SVM: toward automatic plaque assayYihao Mao, Hong Liu, Rong Ye, et al.
International Journal of Biological Sciences|May 22, 2023
B cells in tumor metastasis: friend or foe?Yuqiu Xu, Yihao Mao, Yang Lv, et al.
Sensors (Basel, Switzerland)|May 14, 2025
The Research on Path Planning Method for Detecting Automotive Steering Knuckles Based on Phased Array Ultrasound Point CloudYihao Mao, Jun Tu, Huizhen Wang, et al.
Clinical and Translational Medicine|June 22, 2020
Analysis of tumor microenvironment-related key mRNAs and construction of a prognosis signature in colon cancerZhiyuan Zhang, Guodong He, Qingyang Feng, et al.
Genomics|July 10, 2020
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancerZhiyuan Zhang, Qingyang Feng, Caiwei Jia, et al.
Genomics|June 17, 2020
A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I-III rectal cancerZhiyuan Zhang, Meiling Ji, Yang Lv, et al.
International Journal of Cancer|June 7, 2018
Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancerYihao Mao, Qingyang Feng, Peng Zheng, et al.
Cancers|August 26, 2022
High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon CancerPeng Zheng, Yang Lv, Yihao Mao, et al.
Cancers|October 14, 2022
CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant ChemotherapyJiang Chang, Songbin Lin, Yihao Mao, et al.
Journal of Cancer Research and Clinical Oncology|April 20, 2020
High MICB expression as a biomarker for good prognosis of colorectal cancerQingyang Feng, Shanchao Yu, Yihao Mao, et al.
Pageof 3